Answers are grounded in this paper and cite their sources.
In this study, genetically modified Escherichia coli strains FS60 and FS61 were constructed, engineered for overexpression of acetyl-CoA synthetase (ACS) under promoters of different strengths. Since ACS catalyzes the activation of acetate to acetyl-CoA, its overexpression was hypothesized to alter acetate accumulation and influence recombinant protein formation. Comparative cultivations of these strains in bioreactors were performed alongside the industrial reference strain E. coli BL21. The study aimed to evaluate the effect of ACS overexpression on the accumulation of the toxic secondary metabolite, acetate, and the productivity of the target recombinant protein. Significant reductions in acetate accumulation were observed in E. coli FS61: 66 and 73% at 3 and 4 h after induction, respectively, relative to that in E. coli BL21 during high-density fermentation. In contrast, E. coli FS60, expressing ACS under a stronger promoter, exhibited only 20 and 4% decreases in acetate accumulation at the same time points. These results may indicate that excessive ACS expression under a strong promoter imposes a metabolic burden, possibly disturbing energy flux and, in turn, promoting acetate synthesis rather than its utilization. By comparison, moderate expression driven by the Tac promoter appeared to reduce extracellular acetate accumulation more effectively. Reduced acetate accumulation correlated with improved recombinant protein productivity. ACS overexpression enhanced specific productivity of the target protein in E. coli FS60 by 28 and 40% at 3 and 4 h after induction, respectively, and by 59 and 51% in FS61. However, both genetically engineered strains demonstrated reduced biomass accumulation compared to E. coli BL21, limiting volumetric productivity. This effect may be attributed to the additional metabolic burden imposed by ACS overexpression, which decreases the growth rate of the engineered strains. In conclusion, ACS overexpression enhances cell-specific productivity, but requires further optimization to achieve volumetric productivity comparable to the industrial E. coli BL21 strain. This approach holds promise for industrial biotechnology applications although cultivation conditions require refinement to mitigate metabolic burden and maximize production efficiency.
No takes yet. Share an insight, caveat, or question.
Grechko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: